(Q41514405)

2 October 2017

title

Optimizing the indication of vigabatrin in children with refractory epilepsy (English)

1 reference

2 October 2017

A Lortie

1

1 reference

2 October 2017

C Chiron

2

1 reference

2 October 2017

C Dumas

3

1 reference

2 October 2017

J P Mumford

4

1 reference

2 October 2017

O Dulac

5

1 reference

2 October 2017

publication date

1 June 1997

1 reference

Journal of Child Neurology

2 October 2017

published in

1 reference

2 October 2017

volume

12

1 reference

2 October 2017

issue

4

1 reference

2 October 2017

page(s)

253-259

1 reference

Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Response to vigabatrin in relation to seizure type

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Vigabatrin in intractable childhood epilepsy: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Exacerbation of seizures in children by carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Open study of clobazam in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Vigabatrin in the treatment of epilepsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Vigabatrin in the treatment of infantile spasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Tolerance to anticonvulsant effects of diazepam, clonazepam, and clobazam in amygdala-kindled rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Tolerance to the anticonvulsant effects of clobazam in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Development of tolerance to the anticonvulsant effect of vigabatrin in amygdala-kindled rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Pharmacokinetic effects of vigabatrin on cerebrospinal fluid amino acids in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Selective stabilisation of developing synapses as a mechanism for the specification of neuronal networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

Vigabatrin: clinical evidence supporting rational polytherapy in management of uncontrolled seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307389701200407

10.1177/088307389701200407

21 January 2018

Identifiers

DOI

1 reference

2 October 2017

1 reference